News

請大家密切期待

請大家密切期待

一項在多個研究中心、隨機、雙盲、平行設計、安慰劑對照的研究，旨在評估 UTHEVER® NMN 補充劑的功效和安全性

A Multicentre, Randomised, Double Blind, Parall...

Conclusion: In this study, the rise in NAD+ levels at day 30 and day 60 of /NADH illustrates the potential of UTHEVER to increase NAD+ levels in cells associated with...

A Multicentre, Randomised, Double Blind, Parall...

Conclusion: In this study, the rise in NAD+ levels at day 30 and day 60 of /NADH illustrates the potential of UTHEVER to increase NAD+ levels in cells associated with...